Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

AVL-292 shows promise in models of arthritis and cancer and enters clinical development

Oct. 6, 2010

New mechanism of action of AN-3365 linked to potent activity in Gram-negative bacterial infections

Oct. 6, 2010

Maximum tolerated dose of ARRY-380 established in patients with breast cancer

Oct. 5, 2010

Phase I data support safety of TissueGene-C in osteoarthritis

Oct. 5, 2010

Intranasal XF-73 well tolerated in phase I study

Oct. 5, 2010

Preclinical and clinical data reported on neoglycoside ACHN-490

Oct. 5, 2010

PH-797804 improves lung function in patients with COPD

Oct. 5, 2010

MedImmune reports clinical data on asthma candidates MEDI-563 and MEDI-528

Oct. 5, 2010

Phase II trial of IMA-901 shows benefit of cyclophosphamide pretreatment

Oct. 4, 2010

NNC-126-0083 is well tolerated in adults and children with growth hormone deficiency

Oct. 4, 2010

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...